Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NSCLC × Liquid Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Neoplastic Cells, Circulating 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Salivary Gland Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Mouth Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Disease 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Diseases 1 Adenocarcinoma 1

Interventions

sugemalimab 1 spartalizumab 1 Vinorelbine 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Liquid Biopsy 1 Gemcitabine 1 Gefitinib 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02890849 2024-02-23

RadImm01

Xinqiao Hospital of Chongqing

Phase NA Completed

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡